Osteoprotegerin, IL-6, IL-1, TNF-α and TGF-β concentrations during acetate-free biofiltration

Journal of Nephrology

Volumn 18, Issue 2, 2005, Pages 148-153

  Buemi, Michele ^a,b   Floccari, Fulvio ^a   Crisafulli, Alessandra ^a   Cavallaro, Emanuela ^a   Ruello, Antonella ^a   Caccamo, Chiara ^a   Loddo, Saverio ^a   Aloisi, Carmela ^a   Corica, Francesco ^a   Romeo, Adolfo ^a   Frisina, Nicola ^a   Teti, Diana ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Acetate free biofiltration; Interleukin 1; Interleukin 6; Osteoprotegerin; Transforming growth factor ; Tumor necrosis factor ; Uremic osteodystrophy

Indexed keywords

ACETIC ACID; ALKALINE PHOSPHATASE; CALCIUM; COLECALCIFEROL; INTERLEUKIN 1; INTERLEUKIN 6; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHORUS; POLYACRYLONITRILE; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BIOCHEMISTRY; BIOFILTER; BIOFILTRATION; CLINICAL ARTICLE; CLINICAL OBSERVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; DIALYSIS MEMBRANE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; KIDNEY FAILURE; MALE; STATISTICAL ANALYSIS; TIME; TREATMENT OUTCOME; ULTRAFILTRATION;

ACRYLIC RESINS; AGED; FEMALE; GLYCOPROTEINS; HEMODIAFILTRATION; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; OSTEOPROTEGERIN; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20744449155     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Pertosa G, Grandaliano G, Gesualdo L, Schena FP. Clinical relevance of cytokine production in haemodialysis. Kidney Int 2000; 58 (suppl 76): S4-11.
2. Yan T, Riggs BL, Boyle WJ, Khosla S. Regulation of osteoclastogenesis and RANK expression by TGF-beta1. J Cell Biochem 2001; 83: 320-5.
3. Takai H, Kanematsu M, Yano K, Tsuda E, Higashio K, Ikeda K, Watanabe K, Yamada Y. Transforming growth factor-β stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells. J Biol Chem 1998; 273: 27091-6.
4. Saidenberg Kermanach N, Bessis N, Cohen-Solal M, De Vernejoul MC, Boissier MC. Osteoprotegerin and inflammation. Eur Cytokine Netw 2002: 13: 144-53.
5. Kazama JJ Shigematsu T, Yano K, Tsuda E, Miura M, Iwasaki Y, Kawaguchi Y, Gejyo F, Kurokawa K, Fukagawa M. Increased circulating levels of osteoclastogenesis inhibitory factor (osteoprotegerin) in patients with chronic renal failure. Am J Kidney Dis 2002; 39: 525-32.
6. Coen G, Ballanti P, Balducci A, Calabria S, Fischer MS, Jankovic L, Manni M, Morosetti M, Moscaritolo E, Sardella D, Bonucci E. Serum osteoprotegerin and renal osteodystrophy Nephrol Dial Transplant 2002; 17: 233-8.
7. Onyia JE, Miles RR, Yang X, Halladay DL, Hale J, Glasebrook A, McClure D, Seno G, Churgay L, Chandrasekhar S, Martin TJ. In vivo demonstration that human parathyroid hormon 1-38 inhibits the expression of osteoprotegerin in bone with the kinetics of an immediate early gene. J Bone Miner Res 2000; 15: 863-71.
8. Caglar K, Peng Y, Pupim LB, Flakoll PJ, Levenhagen D, Hakim RM, Ikizler TA. Inflammatory signals associated with hemodialysis. Kidney Int 2000; 62: 1408-19.
9. Hofbauer LC, Dunstan CR, Spelsberg TC, Riggs BL, Khosla S. Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenic protein-2 and cytokines. Biochem Biophys Res Commun 1998; 250: 776-81.
10. Kazama JJ, Kato H, Sato T, Shigematsu T, Fukagawa M, Iwasaki Y, Gejyo F. Circulating osteoprotegerin is not removed through haemodialysis membrane. Nephrol Dial Transplant 2002; 17: 1860.
11. Ferreira A, Ghazali A, Galvao J, Souberbille JC, Jehele PM, Mohan S, Descamps-Latscha B, Oprisiu R, Fournier A, Drueke TB. Effect of type of dialysis membrane on bone in haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1230-8.
12. Bouman CS, van Olden RW, Stoutenbeek CP. Cytokine filtration and adsorption during pre- and post dilution hemofiltration in four different membranes. Blood Purif 1998; 16: 261-8.
13. Goldfarb S, Golper TA. Proinflammatory cytokines and haemofiltration membranes. J Am Soc Nephrol 1994; 5: 228-32.
14. Kellum JA, Dishart MK. Effect of haemofiltration filter adsorption on circulating IL6 levels in septic rats. Crit Care 2002; 6: 429-33.
15. Memoli B. Cytokine production in standard haemodialysis with a new polyethersulfone membrane: a cross-over study. Blood Purif 1999; 17: 149-58.
16. Carrozzi S, Nasini MG, Caviglia PM, Schelotto C, Santoni O, Atti M. Acetate-free biofiltration. Effect on peripheral blood monocyte activation and cytokine release. ASAIO J 1992; 38, 52-4.
17. Higuchi T, Kuno T, Takahashi S, Kanmatsuse K. Chronic effects of long term acetate-free biofiltration on the production of interleukin-1beta and interleukin1 receptor antagonist by peripheral blood mononuclear cells. Am J Nephrol 1997; 17: 428-34.
18. Todeschini M, Macconi D, Fernandez NG. Effect of acetate-free biofiltration and bicarbonate haemodialysis on neutrophil activation. Am J Kidney Dis 2002; 40: 352-60.